TGF-β, which signals through both canonical and noncanonical pathways, was attenuated by nano-immunotherapy; however, further studies are needed to examine the exact signaling mechanism that was targeted by nano-immunotherapy in controlling cardiac fibrosis in Chagas disease. This evidence concerns the gene TGFB1 and Chagas disease.